| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:1392-1399.)
© 2005 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From the Department of Pharmacology and Pharmacotherapy (N.J., L.V., J.T., P.B., Z.N., J.G.P., A.V.), Department of Cardiac Surgery (M.B., G.B.), and First Department of Internal Medicine (C.L.), University of Szeged, and Division for Cardiovascular Pharmacology, Hungarian Academy of Sciences (N.J., J.G.P.), Szeged, Hungary, and Heart Research Program (D.A.L.), National Heart, Lung and Blood Institute, Bethesda, Md.
Correspondence to Professor András Varró, Department of Pharmacology and Pharmacotherapy, University of Szeged, H-6720 Szeged, Dóm tér 12, PO Box 427, Hungary. E-mail a.varro{at}phcol.szote.u-szeged.hu
Received March 17, 2005; revision received July 7, 2005; accepted July 11, 2005.
Background Although pharmacological block of the slow, delayed rectifier potassium current (IKs) by chromanol 293B, L-735,821, or HMR-1556 produces little effect on action potential duration (APD) in isolated rabbit and dog ventricular myocytes, the effect of IKs block on normal human ventricular muscle APD is not known. Therefore, studies were conducted to elucidate the role of IKs in normal human ventricular muscle and in preparations in which both repolarization reserve was attenuated and sympathetic activation was increased by exogenous dofetilide and adrenaline.
Methods and Results Preparations were obtained from undiseased organ donors. Action potentials were measured in ventricular trabeculae and papillary muscles using conventional microelectrode techniques; membrane currents were measured in ventricular myocytes using voltage-clamp techniques. Chromanol 293B (10 µmol/L), L-735,821 (100 nmol/L), and HMR-1556 (100 nmol/L and 1 µmol/L) produced a <12-ms change in APD while pacing at cycle lengths ranging from 300 to 5000 ms, whereas the IKr blockers sotalol and E-4031 markedly lengthened APD. In voltage-clamp experiments, L-735,821 and chromanol 293B each blocked IKs in the presence of E-4031 to block IKr. The E-4031sensitive current (IKr) at the end of a 150-ms-long test pulse to 30 mV was 32.9±6.7 pA (n=8); the L-735,821sensitive current (IKs) magnitude was 17.8±2.94 pA (n=10). During a longer 500-ms test pulse, IKr was not substantially changed (33.6±6.1 pA; n=8), and IKs was significantly increased (49.6±7.24 pA; n=10). On application of an "action potentiallike" test pulse, IKr increased as voltage became more negative, whereas IKs remained small throughout all phases of the action potentiallike test pulse. In experiments in which APD was first lengthened by 50 nmol/L dofetilide and sympathetic activation was increased by 1 µmol/L adrenaline, 1 µmol/L HMR-1556 significantly increased APD by 14.7±3.2% (P<0.05; n=3).
Conclusions Pharmacological IKs block in the absence of sympathetic stimulation plays little role in increasing normal human ventricular muscle APD. However, when human ventricular muscle repolarization reserve is attenuated, IKs plays an increasingly important role in limiting action potential prolongation.
Key Words: arrhythmia electrophysiology ion channels long-QT syndrome potassium channels
Related Article:
Circulation 2005 112: 1376-1378.
This article has been cited by other articles:
![]() |
M. Jiang, X. Xu, Y. Wang, F. Toyoda, X.-S. Liu, M. Zhang, R. B. Robinson, and G.-N. Tseng Dynamic Partnership between KCNQ1 and KCNE1 and Influence on Cardiac IKs Current Amplitude by KCNE2 J. Biol. Chem., June 12, 2009; 284(24): 16452 - 16462. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nattel Delayed-rectifier potassium currents and the control of cardiac repolarization: Noble and Tsien 40 years after J. Physiol., December 15, 2008; 586(24): 5849 - 5852. [Full Text] [PDF] |
||||
![]() |
Y. Rudy, M. J. Ackerman, D. M. Bers, C. E. Clancy, S. R. Houser, B. London, A. D. McCulloch, D. A. Przywara, R. L. Rasmusson, R. J. Solaro, et al. Systems Approach to Understanding Electromechanical Activity in the Human Heart: A National Heart, Lung, and Blood Institute Workshop Summary Circulation, September 9, 2008; 118(11): 1202 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Roden Repolarization Reserve: A Moving Target Circulation, September 2, 2008; 118(10): 981 - 982. [Full Text] [PDF] |
||||
![]() |
L. Xiao, J. Xiao, X. Luo, H. Lin, Z. Wang, and S. Nattel Feedback Remodeling of Cardiac Potassium Current Expression: A Novel Potential Mechanism for Control of Repolarization Reserve Circulation, September 2, 2008; 118(10): 983 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, M. Jiang, K.-L. Hsu, M. Zhang, and G.-N. Tseng KCNQ1 and KCNE1 in the IKs Channel Complex Make State-dependent Contacts in their Extracellular Domains J. Gen. Physiol., June 1, 2008; 131(6): 589 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sims, S. Reisenweber, P. C. Viswanathan, B.-R. Choi, W. H. Walker, and G. Salama Sex, Age, and Regional Differences in L-Type Calcium Current Are Important Determinants of Arrhythmia Phenotype in Rabbit Hearts With Drug-Induced Long QT Type 2 Circ. Res., May 9, 2008; 102(9): e86 - e100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Nicolas, K.-H. Park, A. El Harchi, J. Camonis, R. S. Kass, D. Escande, J. Merot, G. Loussouarn, F. Le Bouffant, and I. Baro IKs response to protein kinase A-dependent KCNQ1 phosphorylation requires direct interaction with microtubules Cardiovasc Res, April 25, 2008; (2008) cvn085v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Boulet, A. J. Labro, A. L. Raes, and D. J. Snyders Role of the S6 C-terminus in KCNQ1 channel gating J. Physiol., December 1, 2007; 585(2): 325 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Gallacher, A. Van de Water, H. van der Linde, A. N. Hermans, H. R. Lu, R. Towart, and P. G.A. Volders In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome Cardiovasc Res, November 1, 2007; 76(2): 247 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ahmad and P. Dorian Drug-induced QT prolongation and proarrhythmia: an inevitable link? Europace, September 1, 2007; 9(suppl_4): iv16 - iv22. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Antoons, P. G. A. Volders, T. Stankovicova, V. Bito, M. Stengl, M. A. Vos, and K. R. Sipido Window Ca2+ current and its modulation by Ca2+ release in hypertrophied cardiac myocytes from dogs with chronic atrioventricular block J. Physiol., February 15, 2007; 579(1): 147 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lengyel, L. Virag, T. Biro, N. Jost, J. Magyar, P. Biliczki, E. Kocsis, R. Skoumal, P. P. Nanasi, M. Toth, et al. Diabetes mellitus attenuates the repolarization reserve in mammalian heart Cardiovasc Res, February 1, 2007; 73(3): 512 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mustapha, L. Pang, and S. Nattel Characterization of the cardiac KCNE1 gene promoter Cardiovasc Res, January 1, 2007; 73(1): 82 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schulze-Bahr Arrhythmia Predisposition: Between Rare Disease Paradigms and Common Ion Channel Gene Variants J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A67 - A78. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stengl, C. Ramakers, D. W. Donker, A. Nabar, A. V. Rybin, R. L.H.M.G. Spatjens, T. van der Nagel, W. K.W.H. Wodzig, K. R. Sipido, G. Antoons, et al. Temporal patterns of electrical remodeling in canine ventricular hypertrophy: Focus on IKs downregulation and blunted {beta}-adrenergic activation Cardiovasc Res, October 1, 2006; 72(1): 90 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varro and J. Gy. Papp Low penetrance, subclinical congenital LQTS: Concealed LQTS or silent LQTS? Cardiovasc Res, June 1, 2006; 70(3): 404 - 406. [Full Text] [PDF] |
||||
![]() |
I. R. Boulet, A. L. Raes, N. Ottschytsch, and D. J. Snyders Functional effects of a KCNQ1 mutation associated with the long QT syndrome Cardiovasc Res, June 1, 2006; 70(3): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Poglajen, M. Fister, B. Radovancevic, and B. Vrtovec Short QT Interval and Atrial Fibrillation in Patients Without Structural Heart Disease J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1905 - 1907. [Full Text] [PDF] |
||||
![]() |
D. M. Roden A New Role for Calmodulin in Ion Channel Biology Circ. Res., April 28, 2006; 98(8): 979 - 981. [Full Text] [PDF] |
||||
![]() |
D. M. Roden and T. Yang Protecting the Heart Against Arrhythmias: Potassium Current Physiology and Repolarization Reserve Circulation, September 6, 2005; 112(10): 1376 - 1378. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |